Thu, Apr 17, 2014, 2:28 PM EDT - U.S. Markets close in 1 hr 32 mins

Recent

% | $
Quotes you view appear here for quick access.

Celgene Corp. (CELG) Message Board

neednewsii 1 post  |  Last Activity: Mar 17, 2014 2:33 PM Member since: Jan 7, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Revlimid patent challenge progressing

    CELG disclosed last week that the claims construction hearing (aka Markman)

    involving a generic Revlimid challenge has been scheduled for April 29. Based on

    this timing, investors should expect an incremental update in June/July (court

    typically releases findings 60 days after hearing). Nonetheless, the most likely

    outcome is that there are no meaningful revisions for CELG's claims and the parties

    advance toward trial around YE14. CELG remains extremely confident in its

    intellectual property position. We believe that sentiment on CELG is bottoming and,
    ultimately, we are optimistic on a positive resolution of the patent estate challenge.

CELG
142.092+0.232(+0.16%)2:27 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.